Brightseed, Haleon Team Up to Use AI for Health Innovation

Global consumer health leader Haleon and artificial intelligence (AI) driven biotechnology company Brightseed have announced a strategic partnership aimed at accelerating the discovery of plant-based small molecules to enhance human health. Central to this collaboration is Brightseed's proprietary AI platform, Forager, which can map biological active compounds from plants and other natural sources and uncover their mechanisms of action on human biology. By integrating the Forager platform into its research infrastructure, Haleon’s scientists can leverage this powerful AI tool to expedite the identification and development of innovative health products derived from natural bioactive compounds. This move aligns with Haleon's mission to deliver health solutions grounded in advanced scientific research. The company plans to utilize Forager to drive advancements in areas such as metabolic health, gut health, and immune system support. Sandrine Alvarado, Haleon’s Vice President and Head of Future Focused R&D, expressed enthusiasm about the partnership: “We are delighted to collaborate with Brightseed. This relationship will significantly enhance our research capabilities and propel us towards major breakthroughs.” She emphasized that the integration of Forager is crucial for accelerating discoveries and innovations based on rigorous scientific standards and technological excellence. “This is a significant step in our journey to develop the next generation of natural health solutions.” Lee Chae, co-founder and CEO of Brightseed, similarly voiced optimism: “Forager not only accelerates the pace of innovation but also opens up unexplored possibilities.” He noted that by embedding Forager into the research ecosystem, Haleon can transform these potential benefits into growth drivers. Chae added, “Forager will aid Haleon in improving everyday health through science-validated, nature-inspired solutions.” Brightseed’s AI-driven approach has already achieved notable successes in understanding the effects of plant compounds on metabolic health, gut health, and immunity. Meanwhile, Haleon is renowned for its robust portfolio of trusted consumer health brands, including Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, Parodontax, and Centrum. These brands span categories such as oral care, pain relief, respiratory health, digestive health, and vitamins, minerals, and supplements, all built on a foundation of scientific innovation and a deep understanding of human needs. The collaboration between Haleon and Brightseed represents a significant milestone in the consumer health industry, blending the strengths of Haleon’s brand influence and scientific expertise with Brightseed’s cutting-edge AI technology. Together, they aim to harness the power of nature and technological advancement to explore new avenues of health innovation. Industry experts have hailed this partnership as a groundbreaking move, highlighting its potential to significantly advance the scientific discovery process for natural health products and speed up market innovations. The combination of Haleon and Brightseed’s capabilities not only enhances the efficiency of drug discovery but also opens up novel therapeutic pathways, particularly in the realm of natural remedies and food supplements. This collaboration underscores a commitment to high-quality scientific research and application, setting new standards for future health product development. Haleon, a leading consumer health company, leverages its extensive brand lineup and deep scientific knowledge to improve people's lives through science and innovation. Brightseed, on the other hand, focuses on using AI to unlock the secrets of nature’s health benefits, working with various companies to expedite the discovery and commercialization of science-validated health solutions. Through this partnership, both companies are poised to achieve multiple important scientific milestones in the coming years, further solidifying Haleon’s leadership in the global consumer health market and demonstrating the vast potential of AI in advancing health research. The integration of Forager into Haleon’s research processes is expected to boost the development of products that address critical health issues, making significant contributions to the well-being of consumers worldwide. This strategic alliance not only highlights the potential of AI in healthcare but also sets a precedent for collaborations that combine natural sources with advanced technology. As Haleon continues to push the boundaries of what is possible in the field of health solutions, Brightseed’s AI platform will play a pivotal role in driving the discovery of new, effective, and naturally inspired compounds. Overall, the partnership between Haleon and Brightseed is viewed by insiders as a game-changer in the consumer health industry, accelerating the pace of innovation and setting new benchmarks for scientific rigor and product development. This collaboration exemplifies the future of health research, where AI and natural sources come together to create meaningful and impactful solutions.